Cargando…

Pushing the Optical Imaging Limits of Cancer with Multi-Frequency-Band Raster-Scan Optoacoustic Mesoscopy (RSOM)

Angiogenesis is a central cancer hallmark, necessary for supporting tumor growth and metastasis. In vivo imaging of angiogenesis is commonly applied, to understand dynamic processes in cancer development and treatment strategies. However, most radiological modalities today assess angiogenesis based...

Descripción completa

Detalles Bibliográficos
Autores principales: Omar, Murad, Schwarz, Mathias, Soliman, Dominik, Symvoulidis, Panagiotis, Ntziachristos, Vasilis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351295/
https://www.ncbi.nlm.nih.gov/pubmed/25748240
http://dx.doi.org/10.1016/j.neo.2014.12.010
_version_ 1782360306170724352
author Omar, Murad
Schwarz, Mathias
Soliman, Dominik
Symvoulidis, Panagiotis
Ntziachristos, Vasilis
author_facet Omar, Murad
Schwarz, Mathias
Soliman, Dominik
Symvoulidis, Panagiotis
Ntziachristos, Vasilis
author_sort Omar, Murad
collection PubMed
description Angiogenesis is a central cancer hallmark, necessary for supporting tumor growth and metastasis. In vivo imaging of angiogenesis is commonly applied, to understand dynamic processes in cancer development and treatment strategies. However, most radiological modalities today assess angiogenesis based on indirect mechanisms, such as the rate of contrast enhancement after contrast agent administration. We studied the performance of raster-scan optoacoustic mesoscopy (RSOM), to directly reveal the vascular network supporting melanoma growth in vivo, at 50 MHz and 100 MHz, through several millimeters of tumor depth. After comparing the performance at each frequency, we recorded, for the first time, high-resolution images of melanin tumor vasculature development in vivo, over a period of several days. Image validation was provided by means of cryo-slice sections of the same tumor after sacrificing the mice. We show how optoacoustic (photoacoustic) mesoscopy reveals a potentially powerful look into tumor angiogenesis, with properties and features that are markedly different than other radiological modalities. This will facilitate a better understanding of tumor’s angiogenesis, and the evaluation of treatment strategies.
format Online
Article
Text
id pubmed-4351295
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Neoplasia Press
record_format MEDLINE/PubMed
spelling pubmed-43512952015-03-09 Pushing the Optical Imaging Limits of Cancer with Multi-Frequency-Band Raster-Scan Optoacoustic Mesoscopy (RSOM) Omar, Murad Schwarz, Mathias Soliman, Dominik Symvoulidis, Panagiotis Ntziachristos, Vasilis Neoplasia Article Angiogenesis is a central cancer hallmark, necessary for supporting tumor growth and metastasis. In vivo imaging of angiogenesis is commonly applied, to understand dynamic processes in cancer development and treatment strategies. However, most radiological modalities today assess angiogenesis based on indirect mechanisms, such as the rate of contrast enhancement after contrast agent administration. We studied the performance of raster-scan optoacoustic mesoscopy (RSOM), to directly reveal the vascular network supporting melanoma growth in vivo, at 50 MHz and 100 MHz, through several millimeters of tumor depth. After comparing the performance at each frequency, we recorded, for the first time, high-resolution images of melanin tumor vasculature development in vivo, over a period of several days. Image validation was provided by means of cryo-slice sections of the same tumor after sacrificing the mice. We show how optoacoustic (photoacoustic) mesoscopy reveals a potentially powerful look into tumor angiogenesis, with properties and features that are markedly different than other radiological modalities. This will facilitate a better understanding of tumor’s angiogenesis, and the evaluation of treatment strategies. Neoplasia Press 2015-03-04 /pmc/articles/PMC4351295/ /pubmed/25748240 http://dx.doi.org/10.1016/j.neo.2014.12.010 Text en © 2015 Neoplasia Press, Inc. Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Omar, Murad
Schwarz, Mathias
Soliman, Dominik
Symvoulidis, Panagiotis
Ntziachristos, Vasilis
Pushing the Optical Imaging Limits of Cancer with Multi-Frequency-Band Raster-Scan Optoacoustic Mesoscopy (RSOM)
title Pushing the Optical Imaging Limits of Cancer with Multi-Frequency-Band Raster-Scan Optoacoustic Mesoscopy (RSOM)
title_full Pushing the Optical Imaging Limits of Cancer with Multi-Frequency-Band Raster-Scan Optoacoustic Mesoscopy (RSOM)
title_fullStr Pushing the Optical Imaging Limits of Cancer with Multi-Frequency-Band Raster-Scan Optoacoustic Mesoscopy (RSOM)
title_full_unstemmed Pushing the Optical Imaging Limits of Cancer with Multi-Frequency-Band Raster-Scan Optoacoustic Mesoscopy (RSOM)
title_short Pushing the Optical Imaging Limits of Cancer with Multi-Frequency-Band Raster-Scan Optoacoustic Mesoscopy (RSOM)
title_sort pushing the optical imaging limits of cancer with multi-frequency-band raster-scan optoacoustic mesoscopy (rsom)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351295/
https://www.ncbi.nlm.nih.gov/pubmed/25748240
http://dx.doi.org/10.1016/j.neo.2014.12.010
work_keys_str_mv AT omarmurad pushingtheopticalimaginglimitsofcancerwithmultifrequencybandrasterscanoptoacousticmesoscopyrsom
AT schwarzmathias pushingtheopticalimaginglimitsofcancerwithmultifrequencybandrasterscanoptoacousticmesoscopyrsom
AT solimandominik pushingtheopticalimaginglimitsofcancerwithmultifrequencybandrasterscanoptoacousticmesoscopyrsom
AT symvoulidispanagiotis pushingtheopticalimaginglimitsofcancerwithmultifrequencybandrasterscanoptoacousticmesoscopyrsom
AT ntziachristosvasilis pushingtheopticalimaginglimitsofcancerwithmultifrequencybandrasterscanoptoacousticmesoscopyrsom